Use of sodium-glucose cotransporter-2 (SGLT2) inhibitors does not appear to raise the risk for fractures in older adults, new research suggests. The data come from
Read more
Home ยป
Despite the extensive recent focus on its cost, insulin use in the United States remains dominated by insulin glargine and other analogs, as well as
Read more
Almost half of young adults with type 2 diabetes develop a potentially blinding eye complication called diabetic retinopathy within a dozen years after diagnosis, new
Read more
ON101 (Fespixon, Oneness Biotech), a first-in-class, macrophage-regulating, wound-healing cream for diabetic foot ulcers has shown benefit over absorbent dressings in a phase 3 trial, with
Read more
Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled
Read more
Millions of US adults aged 70 years and over previously advised to take aspirin for primary prevention would not now have it recommended for routine
Read more
Patients with type 1 diabetes who used insulin degludec as their basal insulin had fewer than half the number of nocturnal hypoglycemia events, compared with
Read more
A novel investigational coformulation of prandial insulin and pramlintide improves blood glucose control and reduces body weight in people with type 1 diabetes, early research
Read more
NEW YORK (Reuters Health) – When metformin fails to sufficiently lower blood glucose levels, it’s better to add a sodium-glucose cotransporter 2 (SGLT2) inhibitor rather
Read more
Dr Erika B. Parente It follows that, as the prevalence of obesity among people with type 1 diabetes mellitus (T1DM) increases, so would the incidence
Read more